This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Heidelberg Biotech Gmbh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Kashi Javaherian: Innovator in Protein Oligomer Research
Introduction
Kashi Javaherian is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the treatment of diseases related to angiogenesis, fibrosis, and cancer. Her innovative approach focuses on the development of protein oligomers that can potentially revolutionize therapeutic methods.
Latest Patents
Kashi Javaherian holds a patent titled "Means and methods for the treatment of angiogenesis-, fibrosis- and cancer-related diseases with protein oligomers comprising NC-1-Fc." This patent describes a method for producing a protein oligomer that includes at least two, and preferably three, heterodimeric human NC-1-Fc proteins. The process involves culturing a host cell that expresses specific fusion proteins and obtaining the desired protein oligomer.
Career Highlights
Kashi is currently associated with Heidelberg Biotech GmbH, where she continues her research and development efforts. Her work has garnered attention for its potential applications in treating serious medical conditions. With a focus on innovative solutions, she has established herself as a key figure in her field.
Collaborations
Kashi collaborates with notable professionals in her industry, including Jürgen Debus and Amir Abdollahi. These partnerships enhance her research capabilities and contribute to the advancement of her projects.
Conclusion
Kashi Javaherian's work exemplifies the intersection of innovation and biotechnology. Her contributions to protein oligomer research hold promise for future medical advancements.